Advertisement

AAPS PharmSciTech

, Volume 6, Issue 4, pp E649–E654 | Cite as

Evaluation of polymerized rosin for the formulation and development of transdermal drug delivery system: A technical note

  • Prashant M. Satturwar
  • Suniket V. Fulzele
  • Avinash K. Dorle
Article

Conclusions

Results from the present study conclude that PR in combination with PVP and with incorporation of dibutyl phthalate (30% wt/wt) produces smooth flexible films with improved tensile strength and percentage elongation. The release rate of drug from films and permeation across skin increases with increase in drug and PVP loading but is independent of film thickness. Patches containing PR:PVP (7:3) show promise for pharmacokinetic and pharmacodynamic performance evaluation in a suitable animal model. In view of the overall results reported in the present study, it may be proposed that PR can be used in the design of a matrix type transdermal drug delivery system to prolong the drug release.

Keywords

polymerized rosin diltiazem hydrochloride matrix system in vitro release in vitro permeation transdermal drug delivery 

References

  1. 1.
    Pathak YV, Shinghatgiri M, Dorle AK. In vivo performance of pentastergum coated aspirin microcapsules.J Microencapsul. 1987;4:107–110.CrossRefGoogle Scholar
  2. 2.
    Sheorey DS, Dorle AK. Release kinetics & drugs from rosin-glycerol ester microcapsules prepared by solvent evaporation technique.J Microencapsul. 1991;8:243–246.CrossRefGoogle Scholar
  3. 3.
    Pathak YV, Dorle AK. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs.Drug Des Deliv. 1990;6:223–227.Google Scholar
  4. 4.
    Ramani CC, Puranik PK, Dorle AK. Study of rosin-maleoabietic acid as a matrix forming materials.Int J Pharm Adv. 1996;1:344–352.Google Scholar
  5. 5.
    Pathak YV, Nikore RL, Dorle AK. Study of rosin and esters as coating materials.Int J Pharm. 1985;24:351–354.CrossRefGoogle Scholar
  6. 6.
    Ramani CC, Puranik PK, Dorle AK. Study of diabietic acid as matrix forming material.Int J Pharm. 1996;137:11–19.CrossRefGoogle Scholar
  7. 7.
    Sahu NH, Mandaogade PM, Deshmukh AM, Meghre VS, Dorle AK. Biodegradation studies of rosin-glycerol ester derivative.J Bioact Comp Polym. 1999;14:344–360.Google Scholar
  8. 8.
    Fulzele SV, Satturwar PM, Dorle AK. Studies on biodegradation and in vivo biocompatibility of novel biomaterials.Eur J Pharm Sci. 2003;20:53–61.CrossRefGoogle Scholar
  9. 9.
    Chien YW. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems.J Pharm Sci. 1983; 72:968–970.CrossRefGoogle Scholar
  10. 10.
    Loftsson T, Gildersleeve N, Border N. The effect of vehicle additives on the transdermal delivery of nitroglycerin.Pharm Res. 1987; 4:436–444.CrossRefGoogle Scholar
  11. 11.
    Corbo M, Liu JC, Chien YW. Bioavailability of propranolol following oral & transdermal administration in rabbits.J Pharm Sci. 1990;79:584–587.CrossRefGoogle Scholar
  12. 12.
    Aqil M, Sultana Y, Ali A. Matrix type transdermal drug delivery systems of metoprolol tartrate: in vitro characterization.Acta Pharm. 2003;53:119–125.Google Scholar
  13. 13.
    Williams AC, Barry BW. Penetration enhancers.Adv Drug Deliv Rev. 2004;56:603–618.CrossRefGoogle Scholar
  14. 14.
    Bohme K. Buprenorphine in a transdermal therapeutic system—a new option.Clin Rheumatol. 2002;21:S13-S16.CrossRefGoogle Scholar
  15. 15.
    Dhanorkar VT, Gawande RS, Gogte BB, Dorle AK. Development and characterization of rosin-based polymer and its application as a cream base.J Cosmet Sci. 2002;53:199–208.Google Scholar
  16. 16.
    Fulzele SV, Satturwar PM, Dorle AK. Polymerized rosin: novel filmforming polymer for drug delivery.Int J Pharm. 2002;249:175–184.CrossRefGoogle Scholar
  17. 17.
    Gigante B, Jones R, Lobo AM, et al. The structure of an abietic acid dimer.J Chem Soc Chem Commun. 1986;22:1038–1039.CrossRefGoogle Scholar
  18. 18.
    Parkin BA, Walter H, inventors. Polymerized rosin product and method of preparation of the same. US patent 3 891 612. June 12, 1975.Google Scholar
  19. 19.
    Gupta R, Mukherjee B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches on povidone-ethylcellulose matrices.Drug Dev Ind Pharm. 2003;29:1–7.CrossRefGoogle Scholar
  20. 20.
    Jain SK, Chaurasia MK, Sabitha M, et al. Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride.Drug Deliv. 2003;10:169–177.CrossRefGoogle Scholar
  21. 21.
    Lee PJ, Langer R, Shastri VP. Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs.Pharm Res. 2003;20:264–269.CrossRefGoogle Scholar
  22. 22.
    Baichwal RW.Advances in drug delivery systems. Bombay, India: MSR foundation; 1983:136–147.Google Scholar
  23. 23.
    British Pharmacopoeia Commission.British Pharmacopoeia. Addendum 1996. London, UK: British Pharmacopoeia Commission; 1996:1761.Google Scholar
  24. 24.
    United States Pharmacopeial Convention.United States Pharmacopeia. 23rd ed. Rockville, MD: United States Pharmacopeial Convention; 1993:1796.Google Scholar
  25. 25.
    Chien YW, Valia KH. Development of a dynamic skin permeation system for long term studies.Drug Dev Ind Pharm. 1984;10:575–599.CrossRefGoogle Scholar
  26. 26.
    Sarpotdar PP, Gaskill JL, Giannini RP. Effect of polyethylene glycol 400 on the penetration of drugs through human cadaver skin in vitro.J Pharm Sci. 1986;75:26–28.CrossRefGoogle Scholar
  27. 27.
    Draize JH, Woodward GS, Calvery HO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucus membrane.J Pharmacol Expt Therap. 1994;82:377–390.Google Scholar
  28. 28.
    Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.J Pharm Sci. 2002;91:2076–2089.CrossRefGoogle Scholar
  29. 29.
    Sood A, Panchagnula R. Role of dissolution studies in controlled release drug delivery system.STP Pharma Sci. 1999;9:157–168.Google Scholar
  30. 30.
    Bodmeier R, Paeratakul O. Theophylline tablets coated with aqueous latexes containing dispersed pore formers.J Pharm Sci. 1990; 79:925–928.CrossRefGoogle Scholar
  31. 31.
    Megrab NA, Williams AC, Barray BW. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation.J Control Release. 1995;36:277–294.CrossRefGoogle Scholar
  32. 32.
    Rao PR, Ramakrishna S, Diwan PV. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use.Pharm Dev Technol. 2000;5:465–472.CrossRefGoogle Scholar
  33. 33.
    Katayose S, Kataoka K. Water soluble polyion complex associates of DNA and poly(ethylene glycol)- poly(l-lysine) block copolymers.Bioconjug Chem. 1997;8:702–707.CrossRefGoogle Scholar
  34. 34.
    Chien YW. Development of transdermal drug delivery system.Drug Dev Ind Pharm. 1987;13:589–651.CrossRefGoogle Scholar
  35. 35.
    Johnson ME, Blankschtein D, Linger R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism.J Pharm Sci. 1997;86:1162–1172.CrossRefGoogle Scholar
  36. 36.
    Burger GT, Cheryl ML. Animal care and facilities. In: Hayes AW, ed.Principals and Methods of Toxicology. 2nd ed. New York, NY: Raven Press Ltd; 1989:521–552.Google Scholar
  37. 37.
    Rao PR, Diwan PV. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.Drug Dev Ind Pharm. 1998;24:327–336.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2005

Authors and Affiliations

  • Prashant M. Satturwar
    • 1
  • Suniket V. Fulzele
    • 1
  • Avinash K. Dorle
    • 1
  1. 1.Department of Pharmaceutical SciencesNagpur University CampusNagpurIndia

Personalised recommendations